MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Constipation"

  • 2018 International Congress

    Pain is correlated with other motor and non-motor symptom in Parkinson’s disease

    Y. Liu, X.Y. Zhu, X.J. Zhang, S.L. Yang, T.Y. Feng, Y.C. Wu (Shanghai, China)

    Objective: Study pain occurrence and appearance in Parkinson’s disease (PD), and its relationship with other motor and non-motor symptoms like constipation and footsteps. Background: The…
  • 2018 International Congress

    Gut microbiota geography in Parkinson’s disease in the world

    M. Hirayama, T. Maeda, T. Minato, M. Itoh, J. Takeda, T. Hamaguchi, M. Katsuno, K. Ohno (Nagoya, Japan)

    Objective: The 16 rRNA analysis and the shotgun metagenome analysis in our cohort were compared with 5 previous reports by others. Background: In PD patients,…
  • 2018 International Congress

    Objective intestinal dysfunction in REM sleep behaviour disorder

    K. Knudsen, T. Fedorova, A. Hansen, M. Sommerauer, AM. Haase, M. Otto, K. Svendsen, K. Ostergaard, K. Krogh, P. Borghammer (Aarhus, Denmark)

    Objective: To study objectively measured intestinal function, defined by intestinal volume, transit times, and colonic motility patterns in patients with idiopathic REM sleep behaviour disorder…
  • 2018 International Congress

    Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease

    Y. Xiaodong, Q. Yiwei, X. Shaoqing, C. Shengdi, X. Qin (Shanghai, China)

    Objective: Emerging evidences suggest that gut microbiota dysbiosis plays a role in Parkinson’s disease (PD). However, the alterations in fecal microbiome in Chinese PD patients…
  • 2017 International Congress

    Helicobacter pylori eradication and risk of Parkinson’s disease in patients with peptic ulcers

    Y.-P. Chang, G.-F. Chiu, Y.-H. Chang, D.-C. Wu (Kaohsiung, Taiwan)

    Objective: To observe the effect of Helicobacter pylori eradication on the incidence of Parkinson's disease Background: The prevalence of Helicobacter pylori (H. pylori) is high in Parkinson's disease (PD)…
  • 2017 International Congress

    Associations of probable REM sleep behavior disorder, constipation, and hyposmia with PD

    K. Hughes, X. Gao, J. Baker, M. Schwarzschild, A. Ascherio (Boston, MA, USA)

    Objective: To estimate the relative risk of PD according to combinations of prodromal features. Background: Clinical PD is preceded by a prodromal period characterized by…
  • 2017 International Congress

    Diagnosis of Irritable Bowel Syndrome Increases Risk of Parkinson’s Disease in the Finnish Population

    T. Mertsalmi, E. Pekkonen, F. Scheperjans (HUS, Finland)

    Objective: To assess risk of Parkinson’s disease in patients with irritable bowel syndrome in the Finnish population. Background: The majority of Parkinson’s disease (PD) patients…
  • 2017 International Congress

    Probiotic correction of intestinal dysbiosis in Parkinson’s disease

    I. Miliukhina, E. Ermolenko, A. Ivanova, M. Kotyleva, A. Suvorov (Saint-Petersburg, Russian Federation)

    Objective: To reveal the effect of probiotic on the content and condition of intestinal microbiota in Parkinson's disease (PD). Background: Constipation is an important non-motor…
  • 2017 International Congress

    Detection of Early Changes in Microbiota Composition in Prodromal Parkinson’s Disease

    J. Boertien, T. Van Laar (Groningen, Netherlands)

    Objective: To identify predictive markers of Parkinson’s disease (PD) in the gut microbiota composition of subjects at risk for developing PD due to a positive…
  • 2016 International Congress

    The prevalence of constipation and irritable bowel syndrome in Parkinson’s disease patients according to Rome III diagnostic criteria

    T. Mishima, J. Fukae, S. Fujioka, K. Inoue, Y. Tsuboi (Fukuoka, Japan)

    Objective: To assess the prevalence of constipation and irritable bowel syndrome (IBS) in Parkinson's disease (PD) patients using Rome III in our cohort. Background: Gastrointestinal…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley